Hantavirus Pulmonary Syndrome
1 clinical trials · Condition
◉ Watch Hantavirus Pulmonary Syndrome
| Record | Firm | Date |
|---|---|---|
| A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome (NCT00001123) | National Institute of Allergy and Infectious Diseases (NIAID) |
Track Hantavirus Pulmonary Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.